Combining Calcium Hydroxylapatite and Hyaluronic Acid Fillers for Aesthetic Indications: Efficacy of an Innovative Hybrid Filler.


Journal

Aesthetic plastic surgery
ISSN: 1432-5241
Titre abrégé: Aesthetic Plast Surg
Pays: United States
ID NLM: 7701756

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 10 04 2021
accepted: 05 07 2021
pubmed: 4 8 2021
medline: 17 3 2022
entrez: 3 8 2021
Statut: ppublish

Résumé

Limited data are available describing effectiveness of combining the use of calcium hydroxylapatite (CaHA) and hyaluronic acid (HA). The authors performed a retrospective chart review of patients injected with a premixed combination of CaHA and a cohesive polydensified matrix (CPM A total of 41 patients were included, all females with a mean age of 47.5 years (range 21-63 years). The mean CR-MASJ score improved from 2.12 at baseline to 0.68 at t = 3 months (SD = 0.69, 95% CI 1.28-1.60) and 1.27 at t = 12 months (SD = 0.74, 95% CI 0.43-0.74). 100% of the subjects had experienced a ≥1-point improvement in CR-MASJ score at t = 3 months, versus 85% at t = 12 months. No adverse events were reported. The results of this study support the volumizing and lifting potential of the hybrid mix CaHA:CPM-HA for treatment of cheeks and jawline. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Sections du résumé

BACKGROUND BACKGROUND
Limited data are available describing effectiveness of combining the use of calcium hydroxylapatite (CaHA) and hyaluronic acid (HA).
METHODS METHODS
The authors performed a retrospective chart review of patients injected with a premixed combination of CaHA and a cohesive polydensified matrix (CPM
RESULTS RESULTS
A total of 41 patients were included, all females with a mean age of 47.5 years (range 21-63 years). The mean CR-MASJ score improved from 2.12 at baseline to 0.68 at t = 3 months (SD = 0.69, 95% CI 1.28-1.60) and 1.27 at t = 12 months (SD = 0.74, 95% CI 0.43-0.74). 100% of the subjects had experienced a ≥1-point improvement in CR-MASJ score at t = 3 months, versus 85% at t = 12 months. No adverse events were reported.
CONCLUSION CONCLUSIONS
The results of this study support the volumizing and lifting potential of the hybrid mix CaHA:CPM-HA for treatment of cheeks and jawline.
LEVEL OF EVIDENCE IV METHODS
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Identifiants

pubmed: 34341855
doi: 10.1007/s00266-021-02479-x
pii: 10.1007/s00266-021-02479-x
pmc: PMC8831259
doi:

Substances chimiques

Dermal Fillers 0
Hyaluronic Acid 9004-61-9
Durapatite 91D9GV0Z28
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-381

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021. The Author(s).

Références

Plast Reconstr Surg. 2017 Sep;140(3):393e-404e
pubmed: 28841604
J Drugs Dermatol. 2017 Jan 1;16(1):68-74
pubmed: 28095536
Aesthetic Plast Surg. 2022 Feb;46(1):373-381
pubmed: 34341855
Am J Drug Alcohol Abuse. 2011 Sep;37(5):446-52
pubmed: 21854289
J Clin Aesthet Dermatol. 2015 Jan;8(1):38-49
pubmed: 25610523
Facial Plast Surg. 2016 Jun;32(3):253-60
pubmed: 27248022
J Cosmet Dermatol. 2020 Aug;19(8):1948-1954
pubmed: 32543088
JAMA Dermatol. 2015 Mar;151(3):271-7
pubmed: 25372511
J Drugs Dermatol. 2013 Sep;12(9):978-84
pubmed: 24002143
J Cosmet Laser Ther. 2010 Oct;12(5):235-41
pubmed: 20825260
Aesthet Surg J. 2021 Aug 13;41(9):1068-1076
pubmed: 32593169
Clin Plast Surg. 2008 Jul;35(3):395-404; discussion 393
pubmed: 18558234
Facial Plast Surg. 2019 Apr;35(2):140-148
pubmed: 30943558
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
Aesthet Surg J. 2020 Jun 15;40(Suppl 1):1-26
pubmed: 32542351
Aesthet Surg J. 2014 Jan 1;34(1):118-32
pubmed: 24334306
Dermatol Surg. 2019 Jan;45(1):117-123
pubmed: 30204733
Clin Interv Aging. 2017 Dec 06;12:2069-2076
pubmed: 29255352
J Craniofac Surg. 2020 Jan/Feb;31(1):e18-e21
pubmed: 31403504
Aesthetic Plast Surg. 2012 Aug;36(4):753-60
pubmed: 22580543
J Drugs Dermatol. 2014 Sep;13(9):1047-52
pubmed: 25226004
Arch Facial Plast Surg. 2006 Mar-Apr;8(2):92-7
pubmed: 16549735
J Cosmet Dermatol. 2017 Jun;16(2):152-161
pubmed: 28247924
J Eval Clin Pract. 2017 Jun;23(3):574-581
pubmed: 27859988
J Cosmet Dermatol. 2017 Sep;16(3):342-347
pubmed: 28675618
J Cosmet Dermatol. 2018 Aug;17(4):617-624
pubmed: 30091260

Auteurs

Nabil Fakih-Gomez (N)

Department of Facial Plastic & Cranio-Maxillo-Facial Surgery, Fakih Hospital, Khaizaran, Lebanon.

Jonathan Kadouch (J)

Practice for Aesthetic Dermatology, ReSculpt Clinic, Amsterdam, The Netherlands. jonathan.kadouch@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH